Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
HIMS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.64 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)29.98M
Market Cap
$11.07B
Enterprise Value$7.03B
Total Cash (Recent Filing)$273.74M
Total Debt (Recent Filing)$63.38M
Price to Earnings (P/E)72.0
Beta2.88
Next Earnings
Aug 11, 2025EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding215,453,900
10 Day Avg. Volume46,083,706
30 Day Avg. Volume29,984,420
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda56.69
Forecast
1Y Price Target
$45.54Price Target Upside-12.36% Downside
Rating ConsensusHold
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
EarningsHims posted a substantial beat in Q1’25 with revenue increasing 111% year-over-year to $586 million, well ahead of estimates.
Market DifferentiationHIMS is differentiated in the market through its trusted brand and personalized offerings.
Strategic HiringThe hiring of Nader Kabbani from Amazon as new COO makes logical sense, as his background aligns well with HIMS' ambitions to be a more scaled, consumer-facing healthcare entity.
Bears Say
GuidanceDespite the strong results and continued strategic progress, Q2 guidance was modestly below expectations, reflecting a decision by Hims to transition its Sexual Health subscriber base to higher-LTV daily and personalized solutions from 'on-demand' offerings.
Revenue GuidanceSecond quarter revenue guidance of $530-$540MM is below the Street and reflects some of the softer macro trends and some of the transition of GLP-1 revenue.
Subscriber Growth1Q subscribers (end of period) of 2.366MM was below VA consensus estimates of 2.406MM and BofA’s estimate of 2.393MM.
---
Ownership Overview
10.27% Insiders
16.26% Mutual Funds
0.19% Other Institutional Investors
53.08% Public Companies and
Individual Investors
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $11.64 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $11.07B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Aug 11, 2025 which is in 91 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on May 05, 2025. The company reported $0.2 earnings per share for the quarter, beating the consensus estimate of $0.121 by $0.079.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Overvalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.15.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 215,453,900 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.2 in its last earnings report, beating expectations of $0.121. Following the earnings report the stock price went up 18.123%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in HIMS
---
Hims & Hers Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$45.54 (-12.36% Downside)
$45.54 (-12.36% Downside)
Blogger Sentiment
Bullish
HIMS Sentiment 82%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 7.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▲ 11.8%
Last 30 Days ▲ 11.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
324.63%
12-Months-Change
Fundamentals
Return on Equity
36.79%
Trailing 12-Months
Asset Growth
99.00%
Trailing 12-Months
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
---
HIMS Company Deck
---
HIMS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter with significant revenue growth, subscriber expansion, and strategic partnerships, particularly in the weight loss category. However, there are expected challenges in transitioning the sexual health vertical and managing gross margins.Read More>---
HIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
---
HIMS Stock 12 Month Forecast
Average Price Target
$45.54
▼(-12.36% Downside)
Technical Analysis
---